Gilead, AstraZeneca and Pfizer may be winners in race for COVID-19 therapeutics and vaccines: GlobalData Read more
COVID-19 vaccines need novel approaches to ensure best balance of safety and efficacy: GlobalData Read more
AstraZeneca’s COVID-19 vaccine data may fall short of desirable protection results: GlobalData Read more
COVID-19 disrupted clinical trials with suspended enrollment more likely to resume: GlobalData Read more
Success of indigenous COVID-19 vaccines will make access easy and affordable in India: GlobalData Read more